Exploring how patient-reported outcomes affect perceptions and behaviors
The Mere-measurement Effect in Patient-reported Outcomes: A Randomized Control Trial With Speech Pathology Patients
This study is testing how different ways of asking about speech disorders can change how people feel and respond, to help make these questions better for everyone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 170 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna) |
| Trial ID | NCT06443073 on ClinicalTrials.gov |
What this trial studies
This study investigates the mere-measurement effect of patient-reported outcomes (PROs) on individuals with speech disorders. It aims to understand how the wording, emotional tone, and frequency of PRO measures influence patient perceptions and behaviors. By examining these factors, the research seeks to identify potential biases in responses and improve the formulation of PRO measures. The study will be conducted entirely online, allowing for a diverse participant pool from around the world.
Who should consider this trial
Good fit: Ideal candidates for this study are adults with strong English skills who are technology savvy and suffer from specific speech-related disorders such as muscle tension dysphonia, ALS, or post-stroke aphasia.
Not a fit: Patients under the age of 18 or those without the specified speech disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved assessment tools that enhance patient engagement and treatment outcomes for those with speech disorders.
How similar studies have performed: Previous studies have shown that the mere-measurement effect can influence behaviors, indicating potential for success in this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients will be required to have a qualifying disorder known to effect speech as identified below. Patients who meet the eligibility criteria will be invited to participate in the study by the researchers. Eligibility will be assessed prior to enrolment recruitment screening. AKH patients are not targeted for this study. All patients, regardless of geographic location around the world, can be recruited. The study is entirely online. Subjects must meet the following inclusion criteria for study entry: * Strong English skills\* * Technology savvy - able to complete online questionnaire * Suffering from one of the following: * Muscle tension dysphonia * Inducible laryngeal obstruction * Amyotrophic lateral sclerosis (ALS) * Patients after a stroke or other brain injury/damage/trauma, (aphasia, dysarthria) * Parkinson's disease Exclusion Criteria: * Under the age of 18
Where this trial is running
Vienna
- Preston Long — Vienna, Austria (Recruiting)
Study contacts
- Study coordinator: Preston Long, PhD
- Email: preston.long@meduniwien.ac.at
- Phone: +43 (0)1 40400-66100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.